Filing
Spy
Filing
Spy
Home
About
KRTX — Karuna Therapeutics Inc - FilingSpy
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
3 holders
Ownership
Activity
2023 Q1
4 of 14 quarters
Total Value
$306.87M
Total Shares
1.69M
Net Share Change
+343.0K
Activity
3 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$272.66M
1.50M
1.3%
ADD
+317.3K
(+26.8%)
Viking Global Investors
$272.66M
1.50M shares
ADD
+317.3K
(+26.8%)
Miller Value Partners
$29.97M
165.0K
1.9%
ADD
+20.0K
(+13.8%)
Miller Value Partners
$29.97M
165.0K shares
ADD
+20.0K
(+13.8%)
Patient Capital Management
$4.25M
23.4K
1.9%
ADD
+5.7K
(+32.1%)
Patient Capital Management
$4.25M
23.4K shares
ADD
+5.7K
(+32.1%)